Mirae Asset Global ETFs Holdings’s Eikon Therapeutics EIKN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio EIKN Stock Details EIKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	+9,981	New	+$102K	﹤0.01%	2690

Other funds holding EIKN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's EIKN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 9,981 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2690 among its holdings.

77 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

Mirae Asset Global ETFs Holdings held 9,981 shares of Eikon Therapeutics worth $130K as of Q2 2026.
Eikon Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Eikon Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2690 holding.
77 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.